|
* Mandatory |
The NDA Group is an independent consulting organization delivering services within outcome oriented drug development focused on the strategic and operational aspects of regulatory affairs. NDA provides assistance to both the Pharmaceutical Industry as well as Regulatory Agencies. The ultimate objective of NDA is to help to develop better medicines that reach the patient without unnecessary delay. NDA achieves this objective by critically reviewing client project development plans with the aim that they are optimized to meet the needs of regulatory authorities and then to help to implement those strategies. NDA strives to bridge the communication gap between "the regulators" and "the regulated" to the benefit of patients.
The NDA Group provides services within several different areas such as regulatory affairs, pharmacovigilance and patient safety and quality assurance. NDA's regulatory consultants have extensive knowledge and experience working with traditional pharmaceuticals, biopharma, medical devices and production processes within the pharmaceutical industry.
The NDA Group also provides expert and strategic advice on development and regulatory strategies and assists the pharmaceutical industry with qualified training.